Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose.
Narcan nasal spray does not require assembly and delivers a consistent, measured dose when used as directed. This prescription product can be used on adults or children and is easily administered by anyone, even those without medical training. The drug is sprayed into one nostril while the patient is lying on his or her back, and can be repeated if necessary. However, it is important to note that it is not a substitute for immediate medical care, and the person administering Narcan nasal spray should seek further immediate medical attention on the patient’s behalf.
Narcan nasal spray is distributed by Adapt Pharma, Inc., of Radnor, Pennsylvania.
See related article FDA rejects Indivior’s nasal spray for opioid overdose available at: http://www.jamestownsun.com/news/nation-and-world/3889664-fda-rejects-indiviors-nasal-spray-opioid-overdose
Source: FDA.gov – November 18, 2015